These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A Front Immunol; 2018; 9():199. PubMed ID: 29467769 [TBL] [Abstract][Full Text] [Related]
23. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation. Selck C; Dominguez-Villar M Front Immunol; 2021; 12():661875. PubMed ID: 34054826 [TBL] [Abstract][Full Text] [Related]
24. Building a CAR-Treg: Going from the basic to the luxury model. Rosado-Sánchez I; Levings MK Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321 [TBL] [Abstract][Full Text] [Related]
25. Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy? Boardman D; Maher J; Lechler R; Smyth L; Lombardi G Biochem Soc Trans; 2016 Apr; 44(2):342-8. PubMed ID: 27068938 [TBL] [Abstract][Full Text] [Related]
26. Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges. Riet T; Chmielewski M Front Immunol; 2022; 13():934343. PubMed ID: 36032080 [TBL] [Abstract][Full Text] [Related]
27. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases? Santamaria-Alza Y; Vasquez G Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005 [TBL] [Abstract][Full Text] [Related]
28. Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Brusko TM; Putnam AL; Bluestone JA Immunol Rev; 2008 Jun; 223():371-90. PubMed ID: 18613848 [TBL] [Abstract][Full Text] [Related]
29. CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII. Rana J; Perry DJ; Kumar SRP; Muñoz-Melero M; Saboungi R; Brusko TM; Biswas M Mol Ther; 2021 Sep; 29(9):2660-2676. PubMed ID: 33940160 [TBL] [Abstract][Full Text] [Related]
30. Foxp3, Regulatory T Cell, and Autoimmune Diseases. Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473 [TBL] [Abstract][Full Text] [Related]
31. Antigen-specific regulatory T cells: are police CARs the answer? Dawson NAJ; Levings MK Transl Res; 2017 Sep; 187():53-58. PubMed ID: 28688236 [TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells: from the bench to the clinic and back. Al Dulaijan BS; Mansouri A; Karnyski J; Azzi J Curr Opin Organ Transplant; 2018 Feb; 23(1):1-7. PubMed ID: 29210727 [TBL] [Abstract][Full Text] [Related]
33. Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance. Scott DW Front Immunol; 2021; 12():742719. PubMed ID: 34552599 [TBL] [Abstract][Full Text] [Related]
34. In Vitro Tailoring of Regulatory T Cells Prior to Cell Therapy. Baeten P; Hellings N; Broux B Trends Mol Med; 2020 Nov; 26(11):1059-1060. PubMed ID: 32978063 [No Abstract] [Full Text] [Related]
35. Manipulating regulatory T cells: a promising strategy to treat autoimmunity. Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117 [TBL] [Abstract][Full Text] [Related]
36. CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection. Jiang S; Lechler RI Inflamm Allergy Drug Targets; 2006 Dec; 5(4):239-42. PubMed ID: 17168794 [TBL] [Abstract][Full Text] [Related]